Assignment:
Supporting Economic Information (Find one article) (Limit 2 page per article)
Compare the cost of the new drugs and main therapeutic alternatives,
a) Costs. Include The AWP, WAC, NADAC, ASP, and FSS per course of drug therapy per indication (i.e., minimum, and maximum)
b) Compare the cost per course of drug therapy of the new drug and the generic drugs used for comparison in clinical trials.
c) Budget impact model. Estimate and discuss the difference in cost of the new drug and the available therapeutic alternatives.
Sources: FDA approved label, Micromedex Redbook (AWP and WAC), CMS (NADAC and ASP), VA (FSS).
Submit the key economic studies that have been conducted, whether published or not. Studies reported in this section should be summarized in a clear, concise format; presenting the data from in a table. All of the following should be included:
1) Perspective
2) Alternatives
3) Costs
4) Health outcomes
5) Type of analysis
6) Main Results
7) Assumptions and limitations
8) Publication citation(s)/references used.
Sources: Published literature.